A wound dressing made using biomaterials is known as bioactive wound care dressings. These materials are designed to come into direct contact with injury and prevent the chances of further infection. The dressings are made of both synthetic and natural polymers. The rise in diabetes and skin injuries from burns is driving the growth of the bioactive wound market.
The global active wound management market is segmented based on product, application and end user. Depending on the product, the market is divided into alginates, collagen dressings, antimicrobial dressings, bioengineered skin substitutes, and hydrocolloids. The alginates segment had the largest market share in 2019; however, the bioengineered skin substitute segment is expected to record the highest CAGR until 2027. Depending on the application, the market is subdivided into pressure sores, diabetic leg ulcers, venous leg ulcers, burns and surgical wounds.
The burn injury segment had the largest market share in 2019, while the surgical injury segment was estimated to have the highest CAGR during the forecast period. Depending on the end user, the biologically active wound management market is divided into hospitals and clinics, outpatient surgical centers, and others. The hospitals and clinics segment had the largest market share in 2019 and is estimated to have also posted the fastest CAGR during the forecast period.
This dynamic and complex process requires the right conditions to accelerate healing. With the advancement of technology, a variety of wound dressings have been developed to treat various types of wounds, targeting different aspects of the healing process. The company "MEDIVO" presents innovative dressings for the treatment of wounds - MIRRAGEN.